BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Torii N, Ichihara A, Mizuguchi Y, Seki Y, Hashimoto E, Tokushige K. Hormone-replacement Therapy for Hepatopulmonary Syndrome and NASH Associated with Hypopituitarism. Intern Med. 2018;57:1741-1745. [PMID: 29910217 DOI: 10.2169/internalmedicine.0027-17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang XY, Yuan K, Fang YL, Wang CL. Growth hormone ameliorates hepatopulmonary syndrome and nonalcoholic steatohepatitis secondary to hypopituitarism in a child: A case report. World J Clin Cases 2022; 10(18): 6211-6217 [DOI: 10.12998/wjcc.v10.i18.6211] [Reference Citation Analysis]
2 Ji W, Nie M, Mao JF, Zhang HB, Wang X, Wu XY. Growth hormone cocktail improves hepatopulmonary syndrome secondary to hypopituitarism: A case report. World J Clin Cases 2021; 9(18): 4852-4858 [PMID: 34222458 DOI: 10.12998/wjcc.v9.i18.4852] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Alabsawy E, Serry Y, Kotha S, Berry P, Tritto G. Hepatopulmonary syndrome as the first and only manifestation of cirrhosis in a patient with hypopituitarism. BMJ Case Rep 2021;14:e244805. [PMID: 34544714 DOI: 10.1136/bcr-2021-244805] [Reference Citation Analysis]
4 Kodama K, Ichihara A, Seki Y, Ikarashi Y, Sagawa T, Kogiso T, Taniai M, Tokushige K. Characteristics of NAFLD Based on Hypopituitarism. Can J Gastroenterol Hepatol 2020;2020:8814435. [PMID: 33102399 DOI: 10.1155/2020/8814435] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
5 Li S, Wang X, Zhao Y, Nie M, Ji W, Mao J, Wu X. Metabolic Effects of Recombinant Human Growth Hormone Replacement Therapy on Juvenile Patients after Craniopharyngioma Resection. Int J Endocrinol 2022;2022:7154907. [PMID: 35846251 DOI: 10.1155/2022/7154907] [Reference Citation Analysis]